DK0954565T3 - Adipogenisk differentiering af humane mesenchymale stamceller - Google Patents

Adipogenisk differentiering af humane mesenchymale stamceller

Info

Publication number
DK0954565T3
DK0954565T3 DK97934171T DK97934171T DK0954565T3 DK 0954565 T3 DK0954565 T3 DK 0954565T3 DK 97934171 T DK97934171 T DK 97934171T DK 97934171 T DK97934171 T DK 97934171T DK 0954565 T3 DK0954565 T3 DK 0954565T3
Authority
DK
Denmark
Prior art keywords
mesenchymal stem
stem cells
differentiate
cells
human mesenchymal
Prior art date
Application number
DK97934171T
Other languages
Danish (da)
English (en)
Inventor
Mark F Pittenger
Original Assignee
Osiris Therapeutics Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Osiris Therapeutics Inc filed Critical Osiris Therapeutics Inc
Application granted granted Critical
Publication of DK0954565T3 publication Critical patent/DK0954565T3/da

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N5/00—Undifferentiated human, animal or plant cells, e.g. cell lines; Tissues; Cultivation or maintenance thereof; Culture media therefor
    • C12N5/06—Animal cells or tissues; Human cells or tissues
    • C12N5/0602—Vertebrate cells
    • C12N5/0652—Cells of skeletal and connective tissues; Mesenchyme
    • C12N5/0653—Adipocytes; Adipose tissue
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/04—Anorexiants; Antiobesity agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N5/00—Undifferentiated human, animal or plant cells, e.g. cell lines; Tissues; Cultivation or maintenance thereof; Culture media therefor
    • C12N5/06—Animal cells or tissues; Human cells or tissues
    • C12N5/0602—Vertebrate cells
    • C12N5/0652—Cells of skeletal and connective tissues; Mesenchyme
    • C12N5/0662—Stem cells
    • C12N5/0663—Bone marrow mesenchymal stem cells (BM-MSC)
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
    • A61K35/12—Materials from mammals; Compositions comprising non-specified tissues or cells; Compositions comprising non-embryonic stem cells; Genetically modified cells
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2501/00—Active agents used in cell culture processes, e.g. differentation
    • C12N2501/01—Modulators of cAMP or cGMP, e.g. non-hydrolysable analogs, phosphodiesterase inhibitors, cholera toxin
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2501/00—Active agents used in cell culture processes, e.g. differentation
    • C12N2501/30—Hormones
    • C12N2501/38—Hormones with nuclear receptors
    • C12N2501/39—Steroid hormones

Landscapes

  • Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Biomedical Technology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Zoology (AREA)
  • Wood Science & Technology (AREA)
  • Genetics & Genomics (AREA)
  • Biotechnology (AREA)
  • General Health & Medical Sciences (AREA)
  • Microbiology (AREA)
  • Rheumatology (AREA)
  • General Engineering & Computer Science (AREA)
  • Biochemistry (AREA)
  • Cell Biology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Veterinary Medicine (AREA)
  • Animal Behavior & Ethology (AREA)
  • Hematology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Developmental Biology & Embryology (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Diabetes (AREA)
  • Child & Adolescent Psychology (AREA)
  • Obesity (AREA)
  • Immunology (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
DK97934171T 1996-07-30 1997-07-21 Adipogenisk differentiering af humane mesenchymale stamceller DK0954565T3 (da)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US08/700,753 US5827740A (en) 1996-07-30 1996-07-30 Adipogenic differentiation of human mesenchymal stem cells
PCT/US1997/012356 WO1998004682A1 (fr) 1996-07-30 1997-07-21 Differentiation adipogene de cellules souches mesenchymateuses humaines

Publications (1)

Publication Number Publication Date
DK0954565T3 true DK0954565T3 (da) 2007-02-05

Family

ID=24814738

Family Applications (1)

Application Number Title Priority Date Filing Date
DK97934171T DK0954565T3 (da) 1996-07-30 1997-07-21 Adipogenisk differentiering af humane mesenchymale stamceller

Country Status (11)

Country Link
US (3) US5827740A (fr)
EP (2) EP0954565B1 (fr)
JP (1) JP2001523084A (fr)
AT (1) ATE342349T1 (fr)
AU (1) AU3729097A (fr)
CA (1) CA2262014C (fr)
DE (1) DE69736814T2 (fr)
DK (1) DK0954565T3 (fr)
ES (1) ES2274547T3 (fr)
PT (1) PT954565E (fr)
WO (1) WO1998004682A1 (fr)

Families Citing this family (192)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5827740A (en) * 1996-07-30 1998-10-27 Osiris Therapeutics, Inc. Adipogenic differentiation of human mesenchymal stem cells
US7037717B1 (en) 1997-03-07 2006-05-02 Chugai Seiyaku Kabushiki Kaisha Cell line and screening method with the use of the same
US6153432A (en) * 1999-01-29 2000-11-28 Zen-Bio, Inc Methods for the differentiation of human preadipocytes into adipocytes
US6777231B1 (en) * 1999-03-10 2004-08-17 The Regents Of The University Of California Adipose-derived stem cells and lattices
US20050076396A1 (en) * 1999-03-10 2005-04-07 Katz Adam J. Adipose-derived stem cells and lattices
US20030082152A1 (en) * 1999-03-10 2003-05-01 Hedrick Marc H. Adipose-derived stem cells and lattices
KR100979664B1 (ko) * 1999-03-10 2010-09-02 유니버시티 오브 피츠버그 오브 더 커먼웰쓰 시스템 오브 하이어 에듀케이션 지방 유래 간세포 및 격자
US8062675B2 (en) 1999-07-07 2011-11-22 Angioblast Systems, Inc. Mesenchymal precursor cell
US20050158289A1 (en) * 1999-07-07 2005-07-21 Simmons Paul J. Mesenchymal precursor cell and use thereof in the repair of bone defects and fractures in mammals
US7670628B2 (en) * 1999-07-07 2010-03-02 Angioblast Systems, Inc. Mesenchymal precursor cell
AU2003901668A0 (en) * 2003-03-28 2003-05-01 Medvet Science Pty. Ltd. Non-haemopoietic precursor cells
AUPQ147799A0 (en) * 1999-07-07 1999-07-29 Medvet Science Pty. Ltd. Mesenchymal precursor cell
WO2001011011A2 (fr) 1999-08-05 2001-02-15 Mcl Llc Cellules souches adultes toutes-puissantes et procede d'isolement
JP2003517858A (ja) * 1999-11-05 2003-06-03 ジェリジーン メディカル コーポレーション 老齢関連の軟組織の欠陥の増強と修復
AU3081801A (en) * 1999-11-15 2001-05-30 Chemclean Corporation Bio-burden visualization system
KR100865664B1 (ko) * 2000-06-14 2008-10-29 비스타겐 인코포레이티드 간 줄기 세포를 사용하는 독성 타이핑
AU2001277539A1 (en) * 2000-07-18 2002-01-30 Societe Des Produits Nestle S.A. Pre-adipose cell lines
DK1349918T3 (da) 2000-12-06 2014-11-10 Anthrogenesis Corp Fremgangsmåde til indsamling af stamceller fra moderkagen
US7311905B2 (en) 2002-02-13 2007-12-25 Anthrogenesis Corporation Embryonic-like stem cells derived from post-partum mammalian placenta, and uses and methods of treatment using said cells
US20080152629A1 (en) * 2000-12-06 2008-06-26 James Edinger Placental stem cell populations
US6869766B2 (en) * 2000-12-22 2005-03-22 The Regents Of The University Of California Gene associated with regulation of adiposity and insulin response
EP3246396B1 (fr) * 2001-02-14 2020-01-29 Celularity, Inc. Rénovation et repopulation de tissus décellularisés et d'organes cadavériques par des cellules souches
EP2316919B1 (fr) 2001-02-14 2015-10-07 Anthrogenesis Corporation Placenta post-gravidique de mammifère, son utilisation et céllules souches placentaires correspondantes
US7585670B2 (en) 2001-12-07 2009-09-08 Cytori Therapeutics, Inc. Automated methods for isolating and using clinically safe adipose derived regenerative cells
US8404229B2 (en) 2001-12-07 2013-03-26 Cytori Therapeutics, Inc. Methods of using adipose derived stem cells to treat acute tubular necrosis
US20050095228A1 (en) * 2001-12-07 2005-05-05 Fraser John K. Methods of using regenerative cells in the treatment of peripheral vascular disease and related disorders
US20050048035A1 (en) 2001-12-07 2005-03-03 Fraser John K. Methods of using regenerative cells in the treatment of stroke and related diseases and disorders
US7595043B2 (en) 2001-12-07 2009-09-29 Cytori Therapeutics, Inc. Method for processing and using adipose-derived stem cells
US9597395B2 (en) 2001-12-07 2017-03-21 Cytori Therapeutics, Inc. Methods of using adipose tissue-derived cells in the treatment of cardiovascular conditions
WO2006075986A1 (fr) * 2005-01-10 2006-07-20 Macropore Biosurgery, Inc. Appareil et procede de suivi, gestion et entretien de dispositifs medicaux
US7514075B2 (en) * 2001-12-07 2009-04-07 Cytori Therapeutics, Inc. Systems and methods for separating and concentrating adipose derived stem cells from tissue
US20060204556A1 (en) * 2001-12-07 2006-09-14 Cytori Therapeutics, Inc. Cell-loaded prostheses for regenerative intraluminal applications
US7771716B2 (en) 2001-12-07 2010-08-10 Cytori Therapeutics, Inc. Methods of using regenerative cells in the treatment of musculoskeletal disorders
US20050008626A1 (en) * 2001-12-07 2005-01-13 Fraser John K. Methods of using adipose tissue-derived cells in the treatment of cardiovascular conditions
KR100930139B1 (ko) * 2001-12-07 2009-12-07 사이토리 테라퓨틱스, 인크. 처리된 리포애스퍼레이트 세포로 환자를 치료하기 위한시스템 및 방법
US20050048036A1 (en) * 2001-12-07 2005-03-03 Hedrick Marc H. Methods of using regenerative cells in the treatment of inherited and acquired disorders of the bone, bone marrow, liver, and other tissues
US7651684B2 (en) * 2001-12-07 2010-01-26 Cytori Therapeutics, Inc. Methods of using adipose tissue-derived cells in augmenting autologous fat transfer
EP1467746A4 (fr) * 2001-12-20 2006-10-04 Macropore Inc Systemes et procedes permettant de traiter des patients avec un materiau riche en collagene extrait de tissus adipeux
EP1469852A4 (fr) * 2002-01-04 2009-12-02 Ford Henry Health System Donneurs de monoxyde d'azote pour le traitement de maladies et de blessures
EP1482916A4 (fr) * 2002-02-07 2007-12-12 Univ Miami Therapie a base des cellules de schwann et des inhibiteurs de phosphodiesterase
JP2005531507A (ja) * 2002-03-02 2005-10-20 ザ ボード オブ リージェンツ，ザ ユニバーシティ オブ テキサス システム ストローマ細胞前駆体による抗癌物質の局所的な産生および／または送達方法
US20050250202A1 (en) * 2002-03-19 2005-11-10 March Keith L Adipose stromal stem cells for tissue and vascular modification
TWI288779B (en) * 2002-03-28 2007-10-21 Blasticon Biotech Forschung Dedifferentiated, programmable stem cells of monocytic origin, and their production and use
KR20040094910A (ko) * 2002-04-03 2004-11-10 아르테셀 사이언스, 인크. 개선된 지방세포 분화된 지방 유래 성체 줄기세포 및 이의용도
US7060494B2 (en) * 2002-04-09 2006-06-13 Reliance Life Sciences Pvt. Ltd. Growth of human Mesenchymal Stem Cells (hMSC) using umbilical cord blood serum and the method for the preparation thereof
JP2005522215A (ja) * 2002-04-12 2005-07-28 セルジーン・コーポレーション 幹細胞及び前駆細胞の分化のモジュレーション、アッセイ、並びにそれらの使用
CN1668733A (zh) * 2002-05-30 2005-09-14 细胞基因公司 利用jnk或mkk抑制剂调节细胞分化并治疗骨髓增生异常和脊髓发育不良综合症的方法
AU2003298775B2 (en) 2002-11-26 2008-07-17 Anthrogenesis Corporation Cytotherapeutics, cytotherapeutic units and methods for treatments using them
WO2004071283A2 (fr) * 2003-02-13 2004-08-26 Anthrogenesis Corporation Utilisation de sang de cordon ombilical pour traiter des individus presentant une maladie, un trouble ou une pathologie
KR100865884B1 (ko) 2003-03-18 2008-10-31 (주)안트로젠 동종 이식에 사용하기 위한 분화된 지방 세포
EP1608411B1 (fr) * 2003-04-01 2010-09-29 United States Government as represented by the Department of Veteran's Affaires Traitement de defaillance multiviscerale faisant intervenir des cellules souches, des cellules precurseurs ou des cellules cibles.
EP1702062A2 (fr) * 2003-06-11 2006-09-20 Jan Remmereit Reprogrammation nucleaire de cellules a des fins therapeutiques
US7012273B2 (en) * 2003-08-14 2006-03-14 Silicon Storage Technology, Inc. Phase change memory device employing thermal-electrical contacts with narrowing electrical current paths
US7569385B2 (en) * 2003-08-14 2009-08-04 The Regents Of The University Of California Multipotent amniotic fetal stem cells
GB0321337D0 (en) * 2003-09-11 2003-10-15 Massone Mobile Advertising Sys Method and system for distributing advertisements
WO2005033297A1 (fr) * 2003-09-19 2005-04-14 The Rockefeller University Compositions, methodes et kits relatifs a la reprogrammation de cellules differenciees adultes et production de cellules du type cellules souches embryonnaires
JP2007508018A (ja) 2003-10-08 2007-04-05 べト−ステム インコーポレイテッド 新規の幹細胞組成物の調製法および使用法、ならびにこの組成物を含有するキット
US7829332B2 (en) * 2004-02-13 2010-11-09 Cornell Research Foundation, Inc. Purines are self-renewal signals for neural stem cells, and purine receptor antagonists promote neuronal and glial differentiation therefrom
US7670596B2 (en) 2004-04-23 2010-03-02 Bioe, Inc. Multi-lineage progenitor cells
US7622108B2 (en) 2004-04-23 2009-11-24 Bioe, Inc. Multi-lineage progenitor cells
KR20070085288A (ko) 2004-09-24 2007-08-27 안지오블라스트 시스템스 인코퍼레이티드 간엽 전구세포의 증식 및/또는 생존성 증강 방법
WO2006052991A2 (fr) 2004-11-11 2006-05-18 The General Hosptial Corporation Activation du recepteur a l'hormone parathyroide et expansion des cellules souches et progenitrices
WO2006062989A1 (fr) * 2004-12-07 2006-06-15 Bacterin International, Inc. Systeme de culture cellulaire tridimensionnel
CA2512667A1 (fr) * 2005-01-07 2006-07-07 Takahiro Ochiya Cellules semblables aux hepatocytes humains et utilisations connexes
CA2608048A1 (fr) * 2005-05-10 2006-11-16 United States Of America Department Of Veteran's Affairs Traitement de nephropathies et de defaillance polyviscerale a l'aide de cellules souches mesenchymateuses et de milieux conditionnes par des cellules souches mesenchymateuses
EP1888741B1 (fr) 2005-05-27 2013-04-17 Viacell, Inc. Traitement de l'ischémie au moyen de cellules souches
US8568761B2 (en) * 2005-07-15 2013-10-29 Cormatrix Cardiovascular, Inc. Compositions for regenerating defective or absent myocardium
US7531355B2 (en) 2005-07-29 2009-05-12 The Regents Of The University Of California Methods and compositions for smooth muscle reconstruction
CA2617611A1 (fr) * 2005-08-01 2007-02-08 Nupotential, Llc Production de cellules reprogrammees presentant un potentiel regenere
AU2006287306A1 (en) 2005-09-09 2007-03-15 Duke University Tissue engineering methods and compositions
DK1957633T3 (en) 2005-10-13 2014-03-17 Anthrogenesis Corp Immunomodulation USING PLACE SPEECH STEM CELLS
US20080070303A1 (en) * 2005-11-21 2008-03-20 West Michael D Methods to accelerate the isolation of novel cell strains from pluripotent stem cells and cells obtained thereby
PT2471904T (pt) * 2005-12-29 2019-02-25 Celularity Inc População de células estaminais placentárias
CN101389754A (zh) 2005-12-29 2009-03-18 人类起源公司 胎盘干细胞和第二来源干细胞的联合培养
US8592209B2 (en) * 2006-01-30 2013-11-26 University Of Virginia Patent Foundation Methods of preparing and characterizing mesenchymal stem cell aggregates and uses thereof
CA2646491A1 (fr) 2006-04-17 2007-10-25 Bioe, Inc. Differenciation des cellules progenitrices a lignees multiples et cellules epitheliales respiratoires
WO2007139551A1 (fr) * 2006-05-30 2007-12-06 Cytori Therapeutics, Inc. Systemes et procedes de manipulation de cellules regeneratives pour tissus adipeux
CN101501185A (zh) * 2006-06-09 2009-08-05 人类起源公司 胎盘巢(placental niche)及其培养干细胞的用途
WO2008013863A2 (fr) * 2006-07-26 2008-01-31 Cytori Therapeutics, Inc. Génération d'un tissu adipeux et d'adipocytes
US7993918B2 (en) 2006-08-04 2011-08-09 Anthrogenesis Corporation Tumor suppression using placental stem cells
JP2010505849A (ja) * 2006-10-06 2010-02-25 ユニバーシティ オブ バージニア パテント ファウンデーション 糖尿病性創傷治癒に有用な方法および組成物
ZA200902233B (en) 2006-10-23 2010-07-28 Anthrogenesis Corp Methods and compositions for treatment of bone defects with placental cell populations
TW200822930A (en) * 2006-11-22 2008-06-01 Chao-Song Hsue Composition for reducing weight and curing hypertriglyceridemia, the effective ingredients thereof containing cyclic AMP, nicotinic acid, prostaglandin, gamma linolenic acid, and xanthine derivates
AU2008216748A1 (en) 2007-02-12 2008-08-21 Anthrogenesis Corporation Hepatocytes and chondrocytes from adherent placental stem cells; and CD34+, CD45- placental stem cell-enriched cell populations
EP3763376A1 (fr) 2007-02-12 2021-01-13 Celularity, Inc. Traitement de maladies inflammatoires au moyen de cellules souches placentaires
US7632340B2 (en) * 2007-03-07 2009-12-15 Hamilton Beach Brands, Inc. Air purifier for removing particles or contaminants from air
EP2607477B1 (fr) 2007-05-03 2020-09-23 The Brigham and Women's Hospital, Inc. Cellules souches multipotentes et leurs utilisations
US8574567B2 (en) * 2007-05-03 2013-11-05 The Brigham And Women's Hospital, Inc. Multipotent stem cells and uses thereof
TWM322542U (en) * 2007-05-23 2007-11-21 Universal Scient Ind Co Ltd Testing machine
CA2693827A1 (fr) * 2007-07-25 2009-01-29 Bioe, Inc. Differenciation de cellules de progeniteur a multiples lignees en chondrocytes
US9200253B1 (en) 2007-08-06 2015-12-01 Anthrogenesis Corporation Method of producing erythrocytes
CA2700613C (fr) * 2007-09-26 2022-09-20 Celgene Cellular Therapeutics Cellules angiogeniques provenant d'un perfusat placentaire humain
NZ599825A (en) 2007-09-28 2014-10-31 Anthrogenesis Corp Tumor suppression using human placental perfusate and human placenta-derived intermediate natural killer cells
KR20170116221A (ko) * 2007-11-07 2017-10-18 안트로제네시스 코포레이션 조산 합병증의 치료에 있어서의 제대혈의 용도
US20100278788A1 (en) * 2008-01-11 2010-11-04 Bone Therapeutics, S.A. Osteogenic Differentiation Of Bone Marrow Stem Cells And Mesenchymal Stem Cells Using A Combination Of Growth Factors
US20100189338A1 (en) * 2008-04-09 2010-07-29 Nexcelom Bioscience Systems and methods for counting cells and biomolecules
JP2011523357A (ja) * 2008-05-06 2011-08-11 ジョスリン ダイアビーティス センター インコーポレイテッド 褐色脂肪細胞分化を誘導するための方法および組成物
JP6097479B2 (ja) 2008-05-07 2017-03-15 ボーン セラピューティクス エス．アー． 新規の間葉系幹細胞及び骨形成性細胞
CA2724839A1 (fr) * 2008-05-21 2009-11-26 Bioe Llc Differenciation de cellules progenitrices de multiples lignees en cellules pancreatiques
EP3124601A1 (fr) * 2008-08-14 2017-02-01 Mesoblast International Sàrl Compositions de cellules souches mésenchymateuses purifiées, et procédés de purification de compositions de cellules souches mésenchymateuses
WO2010021993A1 (fr) 2008-08-19 2010-02-25 Cytori Therapeutics, Inc. Procédés d'utilisation de cellules issues du tissu adipeux dans le traitement du système lymphatique et d'une maladie maligne
WO2010021715A1 (fr) 2008-08-20 2010-02-25 Anthrogenesis Corporation Traitement d'un accident vasculaire cérébral à l'aide de cellules placentaires isolées
KR20240052847A (ko) 2008-08-20 2024-04-23 셀룰래리티 인코포레이티드 개선된 세포 조성물 및 그의 제조 방법
CA2734446C (fr) 2008-08-22 2017-06-20 Anthrogenesis Corporation Methodes et compositions pour le traitement de deficits osseux au moyen de populations de cellules placentaires
EP2182055A1 (fr) 2008-10-14 2010-05-05 Heinrich-Heine-Universität Düsseldorf Cellules souches somatiques sans restrictions dérivées du sang du cordon ombilical humain (USSC)
US20100098739A1 (en) * 2008-10-20 2010-04-22 University Of Virginia Patent Foundation Compositions and methods for modular soft tissue repair
AU2009316541B2 (en) 2008-11-19 2015-08-06 Celularity Inc. Amnion derived adherent cells
US9192695B2 (en) 2008-11-20 2015-11-24 Allosource Allografts combined with tissue derived stem cells for bone healing
NZ592839A (en) * 2008-11-21 2012-10-26 Anthrogenesis Corp Treatment of diseases, disorders or conditions of the lung using placental cells
AU2010242780B2 (en) 2009-05-01 2016-04-21 Puregraft Llc Systems, methods and compositions for optimizing tissue and cell enriched grafts
US9301975B2 (en) 2009-05-01 2016-04-05 Biocardia, Inc. Method of preparing autologous cells and method of use for therapy
US8586360B2 (en) 2009-07-02 2013-11-19 Anthrogenesis Corporation Method of producing erythrocytes without feeder cells
WO2011011477A1 (fr) 2009-07-21 2011-01-27 Abt Holding Company Utilisation de cellules souches pour réduire l'extravasation des leucocytes
WO2011011500A1 (fr) 2009-07-21 2011-01-27 Abt Holding Company Utilisation de cellules souches pour réduire une extravasation de leucocytes
US8697441B2 (en) * 2009-10-08 2014-04-15 Seoul National University Hospital Method of inducing high activity of human adipose stem cell and medium therefor
KR20110038569A (ko) * 2009-10-08 2011-04-14 주식회사 알앤엘바이오 인간 유래 성체 줄기세포를 함유하는 항암용 조성물
US8476227B2 (en) 2010-01-22 2013-07-02 Ethicon Endo-Surgery, Inc. Methods of activating a melanocortin-4 receptor pathway in obese subjects
US9044606B2 (en) 2010-01-22 2015-06-02 Ethicon Endo-Surgery, Inc. Methods and devices for activating brown adipose tissue using electrical energy
DK3284818T3 (da) 2010-01-26 2022-06-20 Celularity Inc Behandling af knoglerelateret kræft ved hjælp af placenta stamceller
DK2539436T3 (da) 2010-02-25 2021-10-18 Abt Holding Co Modulering af makrofagaktivering
LT2556145T (lt) 2010-04-07 2016-11-10 Anthrogenesis Corporation Angiogenezė naudojant placentos kamienines ląsteles
MX2012011543A (es) 2010-04-08 2013-05-06 Anthrogenesis Corp Tratamiento de sarcoidosis empleando celulas madre placentarias.
CA2796251C (fr) 2010-04-13 2019-05-14 Cellular Dynamics International, Inc. Production d'hepatocyte par programmation avancee
EP2582793B1 (fr) 2010-06-15 2017-09-06 Cellular Dynamics International, Inc. Compendium de modèles de cellules souches préfabriqués pour l'interrogation d'une réponse biologique
WO2012006440A2 (fr) 2010-07-07 2012-01-12 Cellular Dynamics International, Inc. Production de cellules endothéliales par programmation
WO2013106655A1 (fr) 2012-01-11 2013-07-18 The Gid Group, Inc. Procédé de traitement de tissu adipeux et appareil de traitement
US9296984B2 (en) 2010-07-09 2016-03-29 The Gid Group, Inc. Tissue processing apparatus and method for processing adipose tissue
US9206387B2 (en) 2010-07-09 2015-12-08 The Gid Group, Inc. Method and apparatus for processing adipose tissue
EP3366327B1 (fr) 2010-07-09 2022-09-21 GID BIO, Inc. Appareil et procédés relatifs à la collecte et au traitement d'un matériel biologique humain contenant des cellules adipeuses
ES2666746T3 (es) 2010-07-13 2018-05-07 Anthrogenesis Corporation Métodos para generar linfocitos citolíticos naturales
CA2809847A1 (fr) * 2010-09-01 2012-03-08 The Regents Of The University Of California Criblage de culture cellulaire pour agents regulant l'adipogenese et la differenciation myofribroplastique
US20120087868A1 (en) 2010-10-08 2012-04-12 Gabriele Todd Nanoparticle-loaded cells
WO2012048276A2 (fr) 2010-10-08 2012-04-12 Caridianbct, Inc. Procédés et systèmes configurables pour la culture et la récolte de cellules dans un système de bioréacteur à fibres creuses
WO2012092049A2 (fr) 2010-12-29 2012-07-05 Ethicon Endo-Surgery, Inc. Modification des adipocytes bruns
US8969315B2 (en) 2010-12-31 2015-03-03 Anthrogenesis Corporation Enhancement of placental stem cell potency using modulatory RNA molecules
SG192124A1 (en) 2011-01-25 2013-08-30 Univ Catholique Louvain Compositions and methods for cell transplantation
CA2826386C (fr) 2011-02-08 2020-04-28 FUJIFILM Cellular Dynamics, Inc. Production de precurseurs hematopoietiques obtenus par programmation
JP6104896B2 (ja) 2011-06-01 2017-03-29 アントフロゲネシス コーポレーション 胎盤幹細胞を使用する疼痛の治療
PL2718416T3 (pl) 2011-06-06 2020-05-18 ReGenesys BVBA Namnażanie komórek macierzystych w bioreaktorach włóknisto-kapilarnych
US10865383B2 (en) 2011-07-12 2020-12-15 Lineage Cell Therapeutics, Inc. Methods and formulations for orthopedic cell therapy
WO2013055476A1 (fr) 2011-09-09 2013-04-18 Anthrogenesis Corporation Traitement de la sclérose latérale amyotrophique au moyen de cellules souches placentaires
BE1020528A3 (fr) 2011-10-11 2013-12-03 Bone Therapeutics Sa Utilisations du facteur de croissance et differenciation 8 (gdf 8).
US20150004144A1 (en) 2011-12-02 2015-01-01 The General Hospital Corporation Differentiation into brown adipocytes
EP2806879B1 (fr) 2012-01-25 2019-03-06 Université Catholique de Louvain Compositions et procédés de transplantation de cellules
WO2013146992A1 (fr) 2012-03-29 2013-10-03 日本ケミカルリサーチ株式会社 Procédé de fabrication de cellules souches pluripotentes dérivées de la pulpe dentaire
EP3075841B1 (fr) 2012-09-06 2021-03-10 GID BIO, Inc. Appareil de traitement de tissus et procédé de traitement de tissu adipeux
PL2900247T3 (pl) 2012-09-26 2018-05-30 Bone Therapeutics S.A. Kompozycje zawierające osocze poddane obróbce rozpuszczalnikiem/detergentem i kwas hialuronowy do zastosowania w leczeniu zaburzeń układu mięśniowo-szkieletowego
WO2014082042A2 (fr) 2012-11-25 2014-05-30 The Regents Of The University Of California Peptides qui stimulent l'adipogenèse sous-cutanée
CN115137753A (zh) 2013-02-05 2022-10-04 细胞结构公司 来自胎盘的自然杀伤细胞
CN105229144A (zh) 2013-02-22 2016-01-06 细胞动力学国际有限公司 通过组合的遗传工程和化学工程经由正向编程产生肝细胞
CA2899713C (fr) 2013-03-15 2022-07-19 Allosource Matrice de collagene repeuplee de cellules pour reparation et regeneration des tissus mous
AU2014248167B2 (en) 2013-04-03 2019-10-10 FUJIFILM Cellular Dynamics, Inc. Methods and compositions for culturing endoderm progenitor cells in suspension
IL289870B2 (en) 2013-04-12 2023-03-01 Lafrancesca Saverio Improving organs for transplantation
AU2014266935B2 (en) 2013-04-30 2020-06-11 Katholieke Universiteit Leuven Cell therapy for myelodysplastic syndromes
US10336980B2 (en) 2013-09-05 2019-07-02 The Gid Group, Inc. Tissue processing apparatus and method for processing adipose tissue
WO2015073913A1 (fr) 2013-11-16 2015-05-21 Terumo Bct, Inc. Expansion de cellules dans un bioréacteur
WO2015148704A1 (fr) 2014-03-25 2015-10-01 Terumo Bct, Inc. Remplacement passif de milieu
US20170107486A1 (en) 2014-04-21 2017-04-20 Cellular Dynamics International, Inc. Hepatocyte production via forward programming by combined genetic and chemical engineering
WO2015184125A1 (fr) 2014-05-28 2015-12-03 The Regents Of The University Of California Peptides, compositions et procédés pour stimuler l'adipogenèse sous-cutanée
EP3193953B1 (fr) 2014-09-19 2020-03-11 Osiris Therapeutics, Inc. Produit de réparation osseuse et ses procédés d'utilisation
US20170296589A1 (en) 2014-09-23 2017-10-19 Case Western Reserve University Compositions and methods for treating lung remodeling diseases
EP3198006B1 (fr) 2014-09-26 2021-03-24 Terumo BCT, Inc. Alimentation programmée
EP3453382B1 (fr) 2014-11-07 2020-08-12 Exostemtech Co., Ltd. Composition comprenant un exosome dérivé de cellules souches pour le blanchiment de la peau ou l'atténuation des rides
KR101629151B1 (ko) * 2014-11-07 2016-06-10 한양대학교 에리카산학협력단 줄기세포 유래 엑소좀을 포함하는 지방세포 분화유도 및 지방조직 재생용 조성물
US10092738B2 (en) 2014-12-29 2018-10-09 Ethicon Llc Methods and devices for inhibiting nerves when activating brown adipose tissue
US10080884B2 (en) 2014-12-29 2018-09-25 Ethicon Llc Methods and devices for activating brown adipose tissue using electrical energy
CN107592789A (zh) 2015-04-23 2018-01-16 骨治疗公司 治疗性细胞的体外保存
WO2017004592A1 (fr) 2015-07-02 2017-01-05 Terumo Bct, Inc. Croissance cellulaire à l'aide de stimuli mécaniques
US11965175B2 (en) 2016-05-25 2024-04-23 Terumo Bct, Inc. Cell expansion
WO2017210537A1 (fr) 2016-06-02 2017-12-07 The Cleveland Clinic Foundation Inhibition du complément pour améliorer la viabilité cellulaire
US11685883B2 (en) 2016-06-07 2023-06-27 Terumo Bct, Inc. Methods and systems for coating a cell growth surface
US11104874B2 (en) 2016-06-07 2021-08-31 Terumo Bct, Inc. Coating a bioreactor
BR112019003871A2 (pt) 2016-08-30 2019-07-16 Lifecell Corp sistemas e métodos para controle de dispositivo médico
USD851777S1 (en) 2017-01-30 2019-06-18 Lifecell Corporation Canister-type device for tissue processing
US12234441B2 (en) 2017-03-31 2025-02-25 Terumo Bct, Inc. Cell expansion
CN117247899A (zh) 2017-03-31 2023-12-19 泰尔茂比司特公司 细胞扩增
US11624046B2 (en) 2017-03-31 2023-04-11 Terumo Bct, Inc. Cell expansion
US11732233B2 (en) 2017-07-18 2023-08-22 Gid Bio, Inc. Adipose tissue digestion system and tissue processing method
RU2020113411A (ru) 2017-10-20 2021-11-22 Боун Терапьютикс Са Способы дифференцировки мезенхимальных стволовых клеток
US11530387B2 (en) 2017-11-16 2022-12-20 Nissan Chemical Corporation Method for inducing differentiation into and producing beige and white adipocytes
SG11202004680UA (en) 2017-11-22 2020-06-29 Mesoblast Int Sarl Cellular compositions and methods of treatment i
KR20210041578A (ko) 2018-07-31 2021-04-15 제이씨알 파마 가부시키가이샤 치수 유래 세포의 제조 방법
BE1026600B1 (fr) 2018-09-25 2020-12-07 Bone Therapeutics Sa Procedes et utilisations pour determiner le potentiel osteogenique de cellules differenciees in vitro
BE1026595B9 (fr) 2018-09-25 2020-11-03 Bone Therapeutics Sa Procedes de differenciation de cellules souches mesenchymateuses
AR118008A1 (es) 2019-02-07 2021-09-08 Vitricell Sa Composiciones para criopreservación de un material biológico
US20220241205A1 (en) 2019-05-13 2022-08-04 Bone Therapeutics Sa Improved Lyophilized Formulations Involving Hyaluronic Acid and Plasmatic Proteins, and Uses Thereof
WO2021007180A1 (fr) 2019-07-05 2021-01-14 Case Western Reserve University Milieu d'amorçage et procédés pour la culture et la thérapie de cellules souches
EP4098267A4 (fr) 2020-01-30 2024-03-06 JCR Pharmaceuticals Co., Ltd. Composition médicinale comprenant des cellules dérivées de pulpe dentaire
US12180506B2 (en) * 2020-10-05 2024-12-31 Mycomagic Biotechnology Co., Ltd. Methods for promoting proliferation and propagation of stem cells
EP4314244B1 (fr) 2021-03-23 2025-07-23 Terumo BCT, Inc. Capture et multiplication cellulaire
US12209689B2 (en) 2022-02-28 2025-01-28 Terumo Kabushiki Kaisha Multiple-tube pinch valve assembly
USD1099116S1 (en) 2022-09-01 2025-10-21 Terumo Bct, Inc. Display screen or portion thereof with a graphical user interface for displaying cell culture process steps and measurements of an associated bioreactor device

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5486359A (en) * 1990-11-16 1996-01-23 Osiris Therapeutics, Inc. Human mesenchymal stem cells
US5827740A (en) * 1996-07-30 1998-10-27 Osiris Therapeutics, Inc. Adipogenic differentiation of human mesenchymal stem cells

Also Published As

Publication number Publication date
CA2262014C (fr) 2010-09-14
AU3729097A (en) 1998-02-20
PT954565E (pt) 2007-01-31
EP0954565A1 (fr) 1999-11-10
CA2262014A1 (fr) 1998-02-05
JP2001523084A (ja) 2001-11-20
EP1659172A1 (fr) 2006-05-24
DE69736814T2 (de) 2007-08-16
US6709864B1 (en) 2004-03-23
DE69736814D1 (de) 2006-11-23
EP0954565A4 (fr) 2002-09-18
US6322784B1 (en) 2001-11-27
EP0954565B1 (fr) 2006-10-11
WO1998004682A1 (fr) 1998-02-05
ATE342349T1 (de) 2006-11-15
US5827740A (en) 1998-10-27
ES2274547T3 (es) 2007-05-16

Similar Documents

Publication Publication Date Title
DK0954565T3 (da) Adipogenisk differentiering af humane mesenchymale stamceller
DE69630955T2 (de) Immortalisierung bzw. desimmortalisierung von zellen
UA37191C2 (uk) Водна структурована композиція поверхнево-активної речовини
ATE382681T1 (de) Verbesserung der herzfunktion durch transplantation mesenchymaler stammzellen
AR003496A1 (es) Procedimiento de tratamiento cosmetico no terapeutico de desordenes asociados con un exceso de sintesis y/o liberacion del cgrp y/o de sustancia p utilizacion de al menos un extracto de celulas de la menos un vegetal de la familia de las iridaceas y composicion cosmetica o farmaceutica que comprende dicho extracto
DK0805853T3 (da) Afstamningsdirigeret induktion af differentiering af humane mesenkyme stamceller
DE60120151D1 (de) Isolierung von mesenchymalen stammzellen und deren verwendung
DK0804163T3 (da) Forbedret fremgangsmåde til stabilisering af biologiske stoffer under tørring og efterfølgende opbevaring samt præparater deraf
ID23877A (id) Senyawa-senyawa dan metode-metode untuk penghambatan ekspresi vcam-1
DK1066052T3 (da) Mesenchymstamceller til forebyggelse og behandling af immunreaktioner ved transplantationer
BG104780A (en) Inhibitors of phospholipase enzymes
PT1117440E (pt) Composicoes farmaceuticas que contem paclitaxel
BR0116309A (pt) Um método para descelularizar material estranho para produzir biopróteses
AP1424A (en) 2-Phenyl-1-[4-(2-aminoethoxy)-benzyl]-indole in combination with estrogens.
DE69433822D1 (de) Humane epithelzellinien der leber
ATE227561T1 (de) Verwendung von alpha-alkylglucosiden und deren estern als antimikrobielle emulgatoren
WO2002051986A3 (fr) Lymphocytes nk eduques et utilisation de ces derniers dans le traitement de troubles lies a l'immunite
ATE356198T1 (de) Definierte systeme zur kultivieurng epithelialer zellen und anwendung derselben
DK0613368T3 (da) Hudregenererende kosmetisk sammensætning
DE69534386D1 (de) Freigabe von intrazellulärem material
FR2749021B1 (fr) Lignees de cellules aviaires immortalisees
TR199700435A2 (xx) Pestisit florolefin bile�imlerinin haz�rlanmas� i�in i�lem ve ara bile�imler.
HK1038700A1 (zh) 含有含羞草属酚类化合物的组合物
TR199801460T2 (xx) Renk stabilize edici(ler) ve s�rfaktan(lar)� i�eren temizleyici bile�im.
TR199902732T2 (xx) Zararl�lar� bertaraf etmek i�in kimyasal y�ntem ve bile�im.